Elizabeth Czerepak

Overview

Elizabeth Czerepak received an average of $863K in total compensation, including $188K in salary, at Scilex Holding Co between 2022 and 2023. Elizabeth Czerepak also received an average of $410K at Cancer Genetics between 2012 and 2013.

Source: SEC filings on March 12, 2024, March 8, 2023, and April 21, 2014.

Related executives

We found ten more executives who work or worked at Scilex Holding Co and Cancer Genetics.

Henry Ji

Scilex Holding Co

Executive Chairperson

Jaisim Shah

Scilex Holding Co

Chief Executive Officer

Stephen Ma

Scilex Holding Co

Chief Financial Officer

John Roberts

Cancer Genetics

Chief Executive Officer

Yung-Ping Yeh

Cancer Genetics

Chief Information Officer

Ralf Brandt

Cancer Genetics

President, Discovery & Early Development Services

Andrew LaFrence

Cancer Genetics

Chief Financial Officer

Panna Sharma

Cancer Genetics

Chief Executive Officer

News

You may also like